Sernova Biotherapeutics (HAM:PSH0) FCF Margin %: 0.00% (As of Apr. 2026)


HAM:PSH0 Sernova Biotherapeutics Inc HAM:PSH0
28 GF Score
Price €0.05
! 2 Warning Signs
View Full Analysis

What is Sernova Biotherapeutics FCF Margin %?

Sernova Biotherapeutics HAM:PSH0 -22.00% 28 FCF Margin % is 0.00% as of Apr. 2026. GuruFocus rates HAM:PSH0 with a GF Score™ of 28/100. The stock has 2 warning signs investors should review. Among 959 Biotechnology companies, Sernova Biotherapeutics ranks worse than 104275.18% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Sernova Biotherapeutics's Free Cash Flow for the three months ended in Apr. 2026 was €-1.37 Mil. Sernova Biotherapeutics's Revenue for the three months ended in Apr. 2026 was €0.00 Mil. Therefore, Sernova Biotherapeutics's FCF Margin % for the quarter that ended in Apr. 2026 was 0.00%.

As of today, Sernova Biotherapeutics's current FCF Yield % is -10.40%.

The historical rank and industry rank for Sernova Biotherapeutics's FCF Margin % or its related term are showing as below:


HAM:PSH0's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -84.65
* Ranked among companies with meaningful FCF Margin % only.

Sernova Biotherapeutics FCF Margin % Related Terms

Sernova Biotherapeutics FCF Margin % Historical Data

* Premium members only.

The historical data trend for Sernova Biotherapeutics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sernova Biotherapeutics FCF Margin % Chart

Sernova Biotherapeutics Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Sernova Biotherapeutics Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

HAM:PSH0 vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Sernova Biotherapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sernova Biotherapeutics FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sernova Biotherapeutics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Sernova Biotherapeutics's FCF Margin % falls into.


HAM:PSH0
28GF Score
Sernova Biotherapeutics Inc HAM:PSH0
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sernova Biotherapeutics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Sernova Biotherapeutics's FCF Margin for the fiscal year that ended in Oct. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Oct. 2025 )/Revenue (A: Oct. 2025 )
=-6.699/0
= %

Sernova Biotherapeutics's FCF Margin for the quarter that ended in Apr. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Apr. 2026 )/Revenue (Q: Apr. 2026 )
=-1.373/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Sernova Biotherapeutics (HAM:PSH0) has a FCF Margin % of 0.00% as of Apr. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Sernova Biotherapeutics and its competitors. According to the industry distribution chart, Sernova Biotherapeutics ranks #999999 out of 959 companies in the Biotechnology industry.
Is Sernova Biotherapeutics' FCF Margin % too high?
Sernova Biotherapeutics' current FCF Margin % is 0.00%. Based on the distribution chart, Sernova Biotherapeutics ranks #999999 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Sernova Biotherapeutics has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Sernova Biotherapeutics' FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Sernova Biotherapeutics ranks #999999 out of 959 companies for FCF Margin %. This places Sernova Biotherapeutics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Sernova Biotherapeutics and its competitors. Sernova Biotherapeutics's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sernova Biotherapeutics stock overvalued right now?
Sernova Biotherapeutics (HAM:PSH0) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Sernova Biotherapeutics' overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Sernova Biotherapeutics (HAM:PSH0), the current FCF Margin % is 0.00% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sernova Biotherapeutics Business Description

Address RPO Central Parkway, PO Box 29592, Mississauga, ON, CAN, L5A 4H2
Sernova Biotherapeutics Inc is a clinical-stage biotechnology company focused on advancing regenerative medicine for the treatment of chronic diseases. The Company's primary asset is its proprietary Cell Pouch, a bio-hybrid organ system designed to enhance the delivery of cell therapy by replicating natural body functions. The Cell Pouch creates a vascularized, organ-like environment that promotes the longevity and functionality of therapeutic cells and ensures containment for retrievability.
28GF Score

Get the complete analysis for HAM:PSH0

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.05
Price